|
1
|
She J, Yang P, Hong Q and Bai C: Lung
cancer in China: Challenges and interventions. Chest.
143:1117–1126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Camps C, del Pozo N, Blasco A, Blasco P
and Sirera R: Importance of quality of life in patients with
non-small-cell lung cancer. Clin Lung Cancer. 10:83–90. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Satgé D, Kempf E, Dubois JB, Nishi M and
Trédaniel J: Challenges in diagnosis and treatment of lung cancer
in people with intellectual disabilities: Current state of
knowledge. Lung Cancer Int. 2016:67876482016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takase N, Hattori Y, Kiriu T, Itoh S, Kawa
Y, Yamamoto M, Urata Y, Shimada T, Tsujino K, Soejima T, et al:
Concurrent chemoradiotherapy with cisplatin and S-1 or vinorelbine
for patients with stage III unresectable non-small cell lung
cancer: A retrospective study. Respir Investig. 54:334–340. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lunacsek OE, Ravelo A, Coutinho AD, Hazard
SJ, Green MR, Willey J, Eaddy M and Goertz HP: First-line treatment
with bevacizumab and platinum doublet combination in non-squamous
non-small cell lung cancer: A retrospective cohort study in US
oncology community practices. Drugs Real World Outcomes. 3:333–343.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Teixeira SF, de Azevedo RA, Silva AC,
Braga RC, Jorge SD, Barbuto JA, Andrade CH and Ferreira AK:
Evaluation of cytotoxic effect of the combination of a pyridinyl
carboxamide derivative and oxaliplatin on NCI-H1299 human non-small
cell lung carcinoma cells. Biomed Pharmacother. 84:1019–1028. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu DL, Huang F and Lu HZ: Drug-resistant
proteins in breast cancer: Recent progress in multidrug resistance.
Ai Zheng. 22:441–444. 2003.(In Chinese). PubMed/NCBI
|
|
8
|
Kim I, Xu W and Reed JC: Cell death and
endoplasmic reticulum stress: Disease relevance and therapeutic
opportunities. Nat Rev Drug Discov. 7:1013–1030. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lage H: An overview of cancer multidrug
resistance: A still unsolved problem. Cell Mol Life Sci.
65:3145–3167. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Joshi AA, Vaidya SS, St-Pierre MV, Mikheev
AM, Desino KE, Nyandege AN, Audus KL, Unadkat JD and Gerk PM:
Placental ABC transporters: Biological impact and pharmaceutical
significance. Pharm Res. 33:2847–2878. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kong LL, Shen GL, Wang ZY, Zhuang XM, Xiao
WB, Yuan M, Gong ZH and Li H: Inhibition of P-glycoprotein and
multidrug resistance-associated protein 2 regulates the
hepatobiliary excretion and plasma exposure of thienorphine and its
glucuronide conjugate. Front Pharmacol. 7:2422016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang NN, Zhao LJ, Wu LN, He MF, Qu JW,
Zhao YB, Zhao WZ, Li JS and Wang JH: Mechanistic analysis of
taxol-induced multidrug resistance in an ovarian cancer cell line.
Asian Pac J Cancer Prev. 14:4983–4988. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sourisseau T, Helissey C, Lefebvre C,
Ponsonnailles F, Malka-Mahieu H, Olaussen KA, André F, Vagner S and
Soria JC: Translational regulation of the mRNA encoding the
ubiquitin peptidase USP1 involved in the DNA damage response as a
determinant of Cisplatin resistance. Cell Cycle. 15:295–302. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zuo J, Jiang H, Zhu YH, Wang YQ, Zhang W
and Luan JJ: Regulation of MAPKs signaling contributes to the
growth inhibition of 1,7-dihydroxy-3,4-dimethoxyxanthone on
multidrug resistance A549/taxol cells. Evid Based Complement
Alternat Med. 2016:20187042016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mao Z, Bian G, Sheng W, He S, Yang J and
Dong X: Adenovirus-mediated IL-24 expression enhances the
chemosensitivity of multidrug-resistantgastric cancer cells to
cisplatin. Oncol Rep. 30:2288–2296. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dash R, Bhutia SK, Azab B, Su ZZ, Quinn
BA, Kegelmen TP, Das SK, Kim K, Lee SG, Park MA, et al:
mda-7/IL-24: A unique member of the IL-10 gene family promoting
cancer-targeted toxicity. Cytokine Growth Factor Rev. 21:381–391.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu J, Sheng W, Xie Y, Shan Y, Miao J,
Xiang J and Yang J: The in vitro and in vivo antitumor activity of
adenovirus-mediated interleukin-24 expression for laryngocarcinoma.
Cancer Biother Radiopharm. 25:29–38. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu X, Xia W, Li S, Blumenfeld J, Zhang B,
Yang J, Miao J and Gu ZJ: Antitumor effect and underlying mechanism
of RGD-modified adenovirus mediated IL-24 expression on myeloid
leukemia cells. Int Immunopharmacol. 28:560–570. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen F, Zhao Q, Wang S, Wang H and Li X:
Upregulation of Id3 inhibits cell proliferation and induces
apoptosis in A549/DDP human lung cancer cells in vitro. Mol Med
Rep. 14:313–318. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie Y, Lv H, Sheng W, Miao J, Xiang J and
Yang J: Synergistic tumor suppression by adenovirus-mediated
inhibitor of growth 4 and interleukin-24 gene cotransfer in
hepatocarcinoma cells. Cancer Biother Radiopharm. 26:681–695. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zheng D, Chen Z, Chen J, Zhuang X, Feng J
and Li J: Exogenous hydrogen sulfide exerts proliferation,
anti-apoptosis, migration effects and accelerates cell cycle
progression in multiple myeloma cells via activating the Akt
pathway. Oncol Rep. 36:1909–1916. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang F, Zou F, Peng Z, Huang D, Wu Y, Chen
Y, Duan C, Cao Y, Mei W, Tang X, et al:
N,N'-dinitrosopiperazine-mediated ezrin protein phosphorylation via
activation of Rho kinase and protein kinase C is involved in
metastasis of nasopharyngeal carcinoma 6-10B cells. J Biol Chem.
286:36956–36967. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kang T, Wei Y, Honaker Y, Yamaguchi H,
Appella E, Hung MC and Piwnica-Worms H: GSK-3 beta targets Cdc25A
for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation
correlates with Cdc25A overproduction in human cancers. Cancer
Cell. 13:36–47. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiao M, Tang Y, Wang YL, Yang L, Li X,
Kuang J and Song GL: ART1 silencing enhances apoptosis of mouse
CT26 cells via the PI3K/Akt/NF-κB pathway. Cell Physiol Biochem.
32:1587–1599. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Y, Zhang P, Qiu F, Chen L, Miao C, Li
J, Xiao W and Ma E: Inactivation of PI3K/Akt signaling mediates
proliferation inhibition and G2/M phase arrest induced by
andrographolide in human glioblastoma cells. Life Sci. 90:962–967.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen W, Zhang S and Zou X: Evaluation on
the incidence, mortality and tendency of lung cancer in China.
Thorac Cancer. 1:35–40. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee PN and Gosney JR: The effect of time
changes in diagnosing lung cancer type on its recorded
distribution, with particular reference to adenocarcinoma. Regul
Toxicol Pharmacol. 81:322–333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mak KS, van Bommel AC, Stowell C, Abrahm
JL, Baker M, Baldotto CS, Baldwin DR, Borthwick D, Carbone DP, Chen
AB, et al Lung Cancer Working Group of ICHOM, : Defining a standard
set of patient-centred outcomes for lung cancer. Eur Respir J.
48:852–860. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yamada K, Ichiki M, Takahashi K, Hisamatsu
Y, Takeoka H, Azuma K, Shukuya T, Nishikawa K, Tokito T, Ishii H,
et al: A multicenter phase II trial of S-1 combined with
bevacizumab after platinum-based chemotherapy in patients with
advanced non-squamous non-small cell lung cancer. Cancer Chemother
Pharmacol. 78:501–507. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Darwish MA, Abo-Youssef AM, Khalaf MM,
Abo-Saif AA, Saleh IG and Abdelghany TM: Vitamin E mitigates
cisplatin-induced nephrotoxicity due to reversal of
oxidative/nitrosative stress, suppression of inflammation and
reduction of total renal platinum accumulation. J Biochem Mol
Toxicol. 31:1–9. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Takara K, Sakaeda T, Kakumoto M,
Tanigawara Y, Kobayashi H, Okumura K, Ohnishi N and Yokoyama T:
Effects of alpha-adrenoceptor antagonist doxazosin on MDR1-mediated
multidrug resistance and transcellular transport. Oncol Res.
17:527–533. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pan XT, Zhu QY, Li DC, Yang JC, Zhang ZX,
Zhu XG and Zhao H: Effect of recombinant adenovirus vector mediated
human interleukin-24 gene transfection on pancreatic carcinoma
growth. Chin Med J. 121:2031–2036. 2008.PubMed/NCBI
|
|
33
|
Zheng SY, Ge JF, Zhao J, Jiang D and Li F:
Adenovirus-mediated IL-24 confers radiosensitization to human lung
adenocarcinoma in vitro and in vivo. Mol Biol Rep. 42:1069–1080.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lv C, Su Q, Liang Y, Hu J and Yuan S:
Oncolytic vaccine virus harbouring the IL-24 gene suppresses the
growth of lung cancer by inducing apoptosis. Biochem Biophys Res
Commun. 476:21–28. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu J, Mo Y, Wang X, Liu J, Zhang X, Wang
J, Hu L, Yang C, Chen L and Wang Y: Conditionally replicative
adenovirus-based mda-7/IL-24 expression enhances sensitivity of
colon cancer cells to 5-fluorouracil and doxorubicin. J
Gastroenterol. 48:203–213. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fang P, Zhang X, Gao Y, Ding CR, Cui F and
Jiao SC: Reversal effect of melanoma differentiation associated
gene-7/interleukin-24 on multidrug resistance in human
hepatocellular carcinoma cells. Anat Rec. 295:1639–1646. 2012.
View Article : Google Scholar
|
|
37
|
Bajaj G, Rodriguez-Proteau R, Venkataraman
A, Fan Y, Kioussi C and Ishmael JE: MDR1 function is sensitive to
the phosphorylation state of myosin regulatory light chain. Biochem
Biophys Res Commun. 398:7–12. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yun UJ, Lee JH, Koo KH, Ye SK, Kim SY, Lee
CH and Kim YN: Lipid raft modulation by Rp1 reverses multidrug
resistance via inactivating MDR-1 and Src inhibition. Biochem
Pharmacol. 85:1441–1453. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yu XS, Du J, Fan YJ, Liu FJ, Cao LL, Liang
N, Xu DG and Zhang JD: Activation of endoplasmic reticulum stress
promotes autophagy and apoptosis and reverses chemoresistance of
human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR
signaling pathway. Oncotarget. 7:76827–76839. 2016.PubMed/NCBI
|
|
40
|
Burris HA III: Overcoming acquired
resistance to anticancer therapy: Focus on the PI3K/AKT/mTOR
pathway. Cancer Chemother Pharmacol. 71:829–842. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mosca E, Barcella M, Alfieri R, Bevilacqua
A, Canti G and Milanesi L: Systems biology of the metabolic network
regulated by the Akt pathway. Biotechnol Adv. 30:131–141. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Polivka J Jr and Janku F: Molecular
targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol
Ther. 142:164–175. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pataer A, Chada S, Roth JA, Hunt KK and
Swisher SG: Development of Ad-mda7/IL-24-resistant lung cancer cell
lines. Cancer Biol Ther. 7:103–108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yang BX, Duan YJ, Dong CY, Zhang F, Gao
WF, Cui XY, Lin YM and Ma XT: Novel functions for mda-7/IL-24 and
IL-24 delE5: Regulation of differentiation of acute myeloid
leukemic cells. Mol Cancer Ther. 10:615–625. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Shi H, Wei LL, Yuan CF, Yang JX, Yi FP, Ma
YP and Song FZ: Melanoma differentiation-associated
gene-7/interleukin 24 inhibits invasion and migration of human
cervical cancer cells in vitro. Saudi Med J. 28:1671–1675.
2007.PubMed/NCBI
|
